中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Mao WEIMIN)

1.EGFR-TKI in non-small cell lung cancer treatment

Weihui ZHENG ; Weimin MAO

Journal of International Oncology 2012;39(8):601-604

2.Therapeutic sensitivity gene SNP in esophageal cancer

Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(12):923-926

3.Status and role of p21cip1 for cancer biological therapy

Wenhu CHEN ; Weimin MAO

Cancer Research and Clinic 2009;21(3):212-215

4.Expression of HLA-G in serum and tissue of cancer patients and its function in tumor immune escape

Wei LIU ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2012;(11):831-833

5.Research progress of nimotuzumab in treatment of esophageal carcinoma

Xiao LIN ; Xiao ZHENG ; Weimin MAO

Cancer Research and Clinic 2015;(7):496-498

6.Study on the Outcome of Acetabular Fractures Operative Treatment

Weimin MAO ; Rongming XU ; Yong HU

Journal of Chinese Physician 2001;0(04):-

7.The application of DNA methylation detection in plasma and tumor tissues in patients with esophageal squamous cell carcinoma

Changchun WANG ; Weimin MAO ; Zhiqiang LING

Chinese Journal of Laboratory Medicine 2012;35(1):37-41

8.miR-21 in gastrointestinal cancer: research progresses

Jiamin YUAN ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(1):45-48

9.hMSH6 polymorphisms and cancer susceptibility

Wei LIU ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(4):243-245

10.Single nucleotide polymorphisms of susceptibility gene in esophageal squamous cell carcinoma

Shizhou YANG ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(12):917-919

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO